Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era

Abstract

Across the range of MELD scores, patients without HCC derived a significant survival benefit when undergoing LDLT rather than waiting for DDLT in the MELD liver allocation era. Low MELD candidates with HCC may not benefit from LDLT.